Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.

Liu, Heng; Frijlink, Henderik W; Huckriede, Anke; van Doorn, Eva; Schmidt, Ed; Leroy, Odile; Rimmelzwaan, Guus; McCullough, Kenneth; Whelan, Mike; Hak, Eelko (2016). Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project. Vaccine, 34(48), pp. 5845-5854. Elsevier 10.1016/j.vaccine.2016.10.040

[img] Text
1-s2.0-S0264410X16309756-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (865kB) | Request a copy

Due to influenza viruses continuously displaying antigenic variation, current seasonal influenza vaccines must be updated annually to include the latest predicted strains. Despite all the efforts put into vaccine strain selection, vaccine production, testing, and administration, the protective efficacy of seasonal influenza vaccines is greatly reduced when predicted vaccine strains antigenically mismatch with the actual circulating strains. Moreover, preparing for a pandemic outbreak is a challenge, because it is unpredictable which strain will cause the next pandemic. The European Commission has funded five consortia on influenza vaccine development under the Seventh Framework Programme for Research and Technological Development (FP7) in 2013. The call of the EU aimed at developing broadly protective influenza vaccines. Here we review the scientific strategies used by the different consortia with respect to antigen selection, vaccine delivery system, and formulation. The issues related to the development of novel influenza vaccines are discussed.

Item Type:

Journal Article (Review Article)

Division/Institute:

05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) > Institute of Virology and Immunology
05 Veterinary Medicine > Research Foci > Host-Pathogen Interaction
05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP)

UniBE Contributor:

McCullough, Kenneth

Subjects:

600 Technology > 630 Agriculture
500 Science > 570 Life sciences; biology

ISSN:

0264-410X

Publisher:

Elsevier

Language:

English

Submitter:

Achim Braun Parham

Date Deposited:

01 Jun 2017 12:31

Last Modified:

01 Jun 2017 12:31

Publisher DOI:

10.1016/j.vaccine.2016.10.040

PubMed ID:

27793486

Uncontrolled Keywords:

Broadly protective; Correlates of protection; EU consortia; Influenza; Vaccines

BORIS DOI:

10.7892/boris.96156

URI:

https://boris.unibe.ch/id/eprint/96156

Actions (login required)

Edit item Edit item
Provide Feedback